Corporate Sponsorship

Corporate support is critical in helping us carry out our mission to fund triple negative research efforts, support women battling the disease, and empower underserved communities.

We know you have many options when considering organizations to support and we welcome the opportunity to work with you. If your company is interested in learning more about sponsorship opportunities with us, please call us at (510) 562-1889 or email

Find Us On:

Follow us on Facebook

Follow us on Twitter

Our Blog:

Fighting To Win Is All We Can Do & We Need To Do It Together !!

August 4, 2013

I have always been a hard-working person, trying to never let anyone down. I love being a mom to my teenage daughter and my three dogs. I have an amazing, supportive husband and we just celebrated our Anniversary of 20 years. I do everything in life to be that good person! I am dedicated to work and my family, paying my bills, going for regular check-ups, and being there for everyone else in their time of need. Basically, I'm just always doing what is RIGHT and GOOD! I now struggle with recently being diagnosed and going through the fight with breast cancer. Who knew that I would eventually find myself with triple negative breast cancer...what did I do wrong? Why me?

Read More »

Bikram Yoga Saved My Life

September 27, 2013

My breast cancer story has a little bit of a different twist than most. I was one who did not discover a lump on my breast. My discovery was via a lump under my armpit which made practicing Bikram Yoga very painful.

Read More »

The BROCADE Study: A Clinical Research Study for People Living with BRCA1/2+ Advanced Breast Cancer

Men and women living with advanced breast cancer due to a BRCA1/2 gene mutation may qualify for a new clinical research study known as the BROCADE Study. This study will determine the safety and effectiveness of veliparib, an experimental anti-cancer drug, in combination with chemotherapy. You may qualify for the study if you are 18 years of age or older, have metastatic or locally recurrent breast cancer and a BRCA1 or 2 mutation, and have not received more than two prior cancer treatments for advanced breast cancer.

People who enroll in the study will be randomized (like flipping a coin) in a 1:1:1 ratio to one of three study treatment groups: veliparib with temozolomide, veliparib with carboplatin and paclitaxel, or placebo with carboplatin and paclitaxel. Temozolomide, carboplatin, and paclitaxel are chemotherapy drugs approved for use in routine cancer care. A placebo is a look-alike pill with no active ingredients. Participants may receive compensation or reimbursement for travel to and from the study center.

If you are interested in learning more about this study, talk to your oncologist, visit the BROCADE Study website at , or call + 1 855 5ONCOLOGY (+ 1 855 566 2656) to speak with an experienced study nurse to determine if the BROCADE Study is right for you.